| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.
|
J Am Coll Cardiol
|
2014
|
9.96
|
|
2
|
Variants conferring risk of atrial fibrillation on chromosome 4q25.
|
Nature
|
2007
|
8.03
|
|
3
|
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study.
|
Lancet
|
2009
|
7.27
|
|
4
|
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.
|
Circulation
|
2014
|
4.56
|
|
5
|
HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).
|
Heart Rhythm
|
2011
|
4.31
|
|
6
|
Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy.
|
Nat Genet
|
2004
|
3.88
|
|
7
|
Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry.
|
Nat Genet
|
2009
|
3.80
|
|
8
|
Genome-wide association study of PR interval.
|
Nat Genet
|
2010
|
3.73
|
|
9
|
Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop.
|
Circulation
|
2009
|
3.50
|
|
10
|
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.
|
Circulation
|
2014
|
3.28
|
|
11
|
Increased incidence of subacute lead perforation noted with one implantable cardioverter-defibrillator.
|
Heart Rhythm
|
2007
|
3.23
|
|
12
|
HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).
|
Europace
|
2011
|
2.54
|
|
13
|
Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium.
|
J Am Heart Assoc
|
2013
|
2.47
|
|
14
|
P wave duration and risk of longitudinal atrial fibrillation in persons ≥ 60 years old (from the Framingham Heart Study).
|
Am J Cardiol
|
2011
|
2.39
|
|
15
|
Atrial fibrillation: current knowledge and future directions in epidemiology and genomics.
|
Circulation
|
2011
|
2.36
|
|
16
|
Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community.
|
Circulation
|
2010
|
2.32
|
|
17
|
Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure.
|
J Am Coll Cardiol
|
2006
|
2.29
|
|
18
|
Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators.
|
Blood
|
2009
|
2.27
|
|
19
|
Adenosine for wide-complex tachycardia: efficacy and safety.
|
Crit Care Med
|
2009
|
2.10
|
|
20
|
Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation.
|
Eur Heart J
|
2009
|
2.06
|
|
21
|
N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study.
|
Circulation
|
2009
|
1.99
|
|
22
|
RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing.
|
Nat Med
|
2012
|
1.97
|
|
23
|
Independent susceptibility markers for atrial fibrillation on chromosome 4q25.
|
Circulation
|
2010
|
1.90
|
|
24
|
European ancestry as a risk factor for atrial fibrillation in African Americans.
|
Circulation
|
2010
|
1.90
|
|
25
|
Mutation in the S3 segment of KCNQ1 results in familial lone atrial fibrillation.
|
Heart Rhythm
|
2009
|
1.87
|
|
26
|
Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy.
|
Heart Rhythm
|
2011
|
1.85
|
|
27
|
In vivo recording of adult zebrafish electrocardiogram and assessment of drug-induced QT prolongation.
|
Am J Physiol Heart Circ Physiol
|
2006
|
1.77
|
|
28
|
Association between familial atrial fibrillation and risk of new-onset atrial fibrillation.
|
JAMA
|
2010
|
1.75
|
|
29
|
Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders.
|
Nat Genet
|
2013
|
1.72
|
|
30
|
Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study.
|
Circ Arrhythm Electrophysiol
|
2010
|
1.70
|
|
31
|
Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathy.
|
Am J Hum Genet
|
2006
|
1.68
|
|
32
|
Cardiac sodium channel gene variants and sudden cardiac death in women.
|
Circulation
|
2007
|
1.67
|
|
33
|
Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities.
|
Circulation
|
2012
|
1.67
|
|
34
|
Impact of segmental left ventricle lead position on cardiac resynchronization therapy outcomes.
|
Heart Rhythm
|
2010
|
1.66
|
|
35
|
Pathological role of serum- and glucocorticoid-regulated kinase 1 in adverse ventricular remodeling.
|
Circulation
|
2012
|
1.65
|
|
36
|
Variation in the 4q25 chromosomal locus predicts atrial fibrillation after coronary artery bypass graft surgery.
|
Circ Cardiovasc Genet
|
2009
|
1.59
|
|
37
|
Lack of replication in polymorphisms reported to be associated with atrial fibrillation.
|
Heart Rhythm
|
2010
|
1.58
|
|
38
|
Identification of a Kir3.4 mutation in congenital long QT syndrome.
|
Am J Hum Genet
|
2010
|
1.57
|
|
39
|
ACE I/D polymorphism associated with abnormal atrial and atrioventricular conduction in lone atrial fibrillation and structural heart disease: implications for electrical remodeling.
|
Heart Rhythm
|
2009
|
1.55
|
|
40
|
Genome-wide association studies of the PR interval in African Americans.
|
PLoS Genet
|
2011
|
1.53
|
|
41
|
Genome-wide association studies in cardiac electrophysiology: recent discoveries and implications for clinical practice.
|
Heart Rhythm
|
2010
|
1.45
|
|
42
|
Increasing US emergency department visit rates and subsequent hospital admissions for atrial fibrillation from 1993 to 2004.
|
Ann Emerg Med
|
2007
|
1.41
|
|
43
|
Case records of the Massachusetts General Hospital. Case 37-2005. A 35-year-old man with cardiac arrest while sleeping.
|
N Engl J Med
|
2005
|
1.38
|
|
44
|
Unpredictable battery depletion of St Jude Atlas II and Atlas+ II HF implantable cardioverter-defibrillators.
|
Heart Rhythm
|
2011
|
1.38
|
|
45
|
P wave indices: current status and future directions in epidemiology, clinical, and research applications.
|
Circ Arrhythm Electrophysiol
|
2009
|
1.35
|
|
46
|
Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation.
|
Circulation
|
2012
|
1.32
|
|
47
|
Genome-wide association studies of atrial fibrillation: past, present, and future.
|
Cardiovasc Res
|
2011
|
1.27
|
|
48
|
Genetics and cardiovascular disease: a policy statement from the American Heart Association.
|
Circulation
|
2012
|
1.26
|
|
49
|
White blood cell count and risk of incident atrial fibrillation (from the Framingham Heart Study).
|
Am J Cardiol
|
2011
|
1.22
|
|
50
|
Overexpression of KCNN3 results in sudden cardiac death.
|
Cardiovasc Res
|
2013
|
1.21
|
|
51
|
Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study.
|
Circulation
|
2012
|
1.17
|
|
52
|
Relation of circulating liver transaminase concentrations to risk of new-onset atrial fibrillation.
|
Am J Cardiol
|
2012
|
1.17
|
|
53
|
Factors affecting error in integration of electroanatomic mapping with CT and MR imaging during catheter ablation of atrial fibrillation.
|
J Interv Card Electrophysiol
|
2007
|
1.17
|
|
54
|
Genetics of atrial fibrillation.
|
Heart Fail Clin
|
2010
|
1.15
|
|
55
|
Clinical subtypes of lone atrial fibrillation.
|
Pacing Clin Electrophysiol
|
2005
|
1.12
|
|
56
|
P-wave indices, distribution and quality control assessment (from the Framingham Heart Study).
|
Ann Noninvasive Electrocardiol
|
2010
|
1.12
|
|
57
|
Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation.
|
Circulation
|
2014
|
1.11
|
|
58
|
A common connexin-40 gene promoter variant affects connexin-40 expression in human atria and is associated with atrial fibrillation.
|
Circ Arrhythm Electrophysiol
|
2010
|
1.09
|
|
59
|
P wave duration is associated with cardiovascular and all-cause mortality outcomes: the National Health and Nutrition Examination Survey.
|
Heart Rhythm
|
2010
|
1.09
|
|
60
|
Atrial fibrillation in congestive heart failure.
|
Heart Fail Clin
|
2010
|
1.07
|
|
61
|
Large-scale candidate gene analysis in whites and African Americans identifies IL6R polymorphism in relation to atrial fibrillation: the National Heart, Lung, and Blood Institute's Candidate Gene Association Resource (CARe) project.
|
Circ Cardiovasc Genet
|
2011
|
1.06
|
|
62
|
Catheter ablation of peri-AV nodal atrial tachycardia from the noncoronary cusp of the aortic valve.
|
J Cardiovasc Electrophysiol
|
2007
|
1.02
|
|
63
|
MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism.
|
J Transl Med
|
2011
|
1.01
|
|
64
|
Genetics and genomics for the prevention and treatment of cardiovascular disease: update: a scientific statement from the American Heart Association.
|
Circulation
|
2013
|
1.01
|
|
65
|
Novel chemical suppressors of long QT syndrome identified by an in vivo functional screen.
|
Circulation
|
2010
|
1.01
|
|
66
|
Genetics of atrial fibrillation: implications for future research directions and personalized medicine.
|
Circ Arrhythm Electrophysiol
|
2010
|
1.01
|
|
67
|
Ion channel mutations in AF: signal or noise?
|
Heart Rhythm
|
2008
|
0.99
|
|
68
|
Pulmonary vein isolation with complex fractionated atrial electrogram ablation for paroxysmal and nonparoxysmal atrial fibrillation: A meta-analysis.
|
Heart Rhythm
|
2011
|
0.98
|
|
69
|
Electrocardiographic PR interval and adverse outcomes in older adults: the Health, Aging, and Body Composition study.
|
Circ Arrhythm Electrophysiol
|
2012
|
0.98
|
|
70
|
American Heart Association atrial fibrillation research summit: a conference report from the American Heart Association.
|
Circulation
|
2011
|
0.97
|
|
71
|
Novel loci associated with PR interval in a genome-wide association study of 10 African American cohorts.
|
Circ Cardiovasc Genet
|
2012
|
0.97
|
|
72
|
Genetics of atrial fibrillation.
|
Cardiol Clin
|
2009
|
0.96
|
|
73
|
Emerging directions in the genetics of atrial fibrillation.
|
Circ Res
|
2014
|
0.96
|
|
74
|
Next steps in cardiovascular disease genomic research--sequencing, epigenetics, and transcriptomics.
|
Clin Chem
|
2011
|
0.95
|
|
75
|
Aging syndrome genes and premature coronary artery disease.
|
BMC Med Genet
|
2005
|
0.95
|
|
76
|
Monogenic atrial fibrillation as pathophysiological paradigms.
|
Cardiovasc Res
|
2010
|
0.94
|
|
77
|
Plasma resistin, adiponectin, and risk of incident atrial fibrillation: the Framingham Offspring Study.
|
Am Heart J
|
2011
|
0.94
|
|
78
|
Impact of ancestry and common genetic variants on QT interval in African Americans.
|
Circ Cardiovasc Genet
|
2012
|
0.94
|
|
79
|
Risk assessment for incident heart failure in individuals with atrial fibrillation.
|
Eur J Heart Fail
|
2013
|
0.94
|
|
80
|
The QT interval and risk of incident atrial fibrillation.
|
Heart Rhythm
|
2013
|
0.93
|
|
81
|
Effectiveness of cardiac resynchronization therapy in mild congestive heart failure: systematic review and meta-analysis of randomized trials.
|
Eur J Heart Fail
|
2010
|
0.90
|
|
82
|
Vitamin D status is not related to development of atrial fibrillation in the community.
|
Am Heart J
|
2011
|
0.89
|
|
83
|
Atrial fibrillation patterns and risks of subsequent stroke, heart failure, or death in the community.
|
J Am Heart Assoc
|
2013
|
0.88
|
|
84
|
Association of sex hormones, aging, and atrial fibrillation in men: the Framingham Heart Study.
|
Circ Arrhythm Electrophysiol
|
2014
|
0.87
|
|
85
|
Influence of race on atrial fibrillation after cardiac surgery.
|
Circ Arrhythm Electrophysiol
|
2011
|
0.87
|
|
86
|
P-wave indices: derivation of reference values from the Framingham Heart Study.
|
Ann Noninvasive Electrocardiol
|
2010
|
0.86
|
|
87
|
Myocardial blood flow and oxygen consumption in patients with Friedreich's ataxia prior to the onset of cardiomyopathy.
|
Coron Artery Dis
|
2007
|
0.86
|
|
88
|
A Novel Transgenic Mouse Model of Cardiac Hypertrophy and Atrial Fibrillation.
|
J Atr Fibrillation
|
2012
|
0.86
|
|
89
|
The impact of new and emerging clinical data on treatment strategies for atrial fibrillation.
|
J Cardiovasc Electrophysiol
|
2010
|
0.86
|
|
90
|
Electrocardiographic Early Repolarization: A Scientific Statement From the American Heart Association.
|
Circulation
|
2016
|
0.86
|
|
91
|
Reciprocal relations between physical disability, subjective health, and atrial fibrillation: the Framingham Heart Study.
|
Am Heart J
|
2013
|
0.85
|
|
92
|
New advances in the genetic basis of atrial fibrillation.
|
J Cardiovasc Electrophysiol
|
2012
|
0.84
|
|
93
|
Stroke risk in AF: do AF patterns matter?
|
Eur Heart J
|
2010
|
0.84
|
|
94
|
Evaluation of non-synonymous NPPA single nucleotide polymorphisms in atrial fibrillation.
|
Europace
|
2010
|
0.84
|
|
95
|
Elevation of parathyroid hormone levels in atrial fibrillation.
|
J Am Coll Cardiol
|
2011
|
0.83
|
|
96
|
The efficacy of implantable cardioverter-defibrillators in heart transplant recipients: results from a multicenter registry.
|
Circ Heart Fail
|
2009
|
0.83
|
|
97
|
Challenges in the classification of atrial fibrillation.
|
Nat Rev Cardiol
|
2010
|
0.83
|
|
98
|
Insulin resistance and atrial fibrillation (from the Framingham Heart Study).
|
Am J Cardiol
|
2011
|
0.83
|
|
99
|
Age of natural menopause and atrial fibrillation: the Framingham Heart Study.
|
Am Heart J
|
2012
|
0.83
|
|
100
|
Amiodarone or procainamide for the termination of sustained stable ventricular tachycardia: an historical multicenter comparison.
|
Acad Emerg Med
|
2010
|
0.83
|
|
101
|
Sequencing of SCN5A identifies rare and common variants associated with cardiac conduction: Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium.
|
Circ Cardiovasc Genet
|
2014
|
0.81
|
|
102
|
A meta-analysis of genome-wide association studies of the electrocardiographic early repolarization pattern.
|
Heart Rhythm
|
2012
|
0.81
|
|
103
|
The diagnosis and treatment of cardiac ion channelopathies: congenital long QT syndrome and Brugada syndrome.
|
Curr Treat Options Cardiovasc Med
|
2007
|
0.79
|
|
104
|
Renin-angiotensin-system modulators and the incidence of atrial fibrillation following hospitalization for coronary artery disease.
|
Europace
|
2012
|
0.78
|
|
105
|
Genetic loci associated with atrial fibrillation: relation to left atrial structure in the Framingham Heart Study.
|
J Am Heart Assoc
|
2014
|
0.78
|
|
106
|
Intermittent, erratic behaviour of an implantable cardioverter defibrillator secondary to a hidden magnetic source of interference.
|
Europace
|
2011
|
0.78
|
|
107
|
Rare ion channel polymorphisms: separating signal from noise.
|
Heart Rhythm
|
2010
|
0.76
|
|
108
|
A common connexion between gap junctions, single nucleotide polymorphisms, and atrial fibrillation?
|
Can J Cardiol
|
2012
|
0.76
|
|
109
|
Genetic screening and risk assessment in hypertrophic cardiomyopathy.
|
J Am Coll Cardiol
|
2004
|
0.76
|
|
110
|
Genetic etiology and evaluation of sudden cardiac death.
|
Curr Cardiol Rep
|
2013
|
0.76
|
|
111
|
Personalized medicine and atrial fibrillation: will it ever happen?
|
BMC Med
|
2012
|
0.76
|
|
112
|
Polymorphisms and atrial fibrillation: sorting the wheat from the chaff.
|
Eur Heart J
|
2008
|
0.75
|
|
113
|
Risk stratification in the long-QT syndrome.
|
N Engl J Med
|
2003
|
0.75
|
|
114
|
Ablation of atrial flutter in a patient with situs inversus totalis using integration of real-time three-dimensional electroanatomical mapping.
|
J Cardiovasc Electrophysiol
|
2007
|
0.75
|
|
115
|
Atrial fibrillation and death after myocardial infarction: risk marker or causal mediator?
|
Circulation
|
2011
|
0.75
|
|
116
|
Impact of the multicenter automatic defibrillator implantation trial on clinical practice.
|
Ann Noninvasive Electrocardiol
|
2006
|
0.75
|
|
117
|
Erratum: Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation.
|
Nat Genet
|
2017
|
0.75
|
|
118
|
Fungal infection of implantable cardioverter-defibrillators: case series of five patients managed over 22 years.
|
Heart Rhythm
|
2006
|
0.75
|
|
119
|
Erratum: Genetic loci associated with heart rate variability and their effects on cardiac disease risk.
|
Nat Commun
|
2017
|
0.75
|
|
120
|
Fifteen Genetic Loci Associated With the Electrocardiographic P Wave.
|
Circ Cardiovasc Genet
|
2017
|
0.75
|